Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Randomized, Double-Blind Trial of Bromocriptine Efficacy in Nonfluent Aphasia After Stroke Publisher Pubmed



Ashtary F1 ; Janghorbani M1, 2 ; Chitsaz A1 ; Reisi M1 ; Bahrami A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology and Epidemiology, Isfahan University, Medical Sciences and Health Services, Iran
  2. 2. Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Neurology Published:2006


Abstract

The authors assessed the efficacy of bromocriptine in nonfluent aphasia after stroke in a 16-week, randomized, double-blind, placebo-controlled clinical trial conducted from June 2002 to April 2004. In all 38 patients after 4 months of treatment, improvement in both the bromocriptine and placebo treatment groups was observed (p < 0.001). The analysis of repeated-measures analysis of variance revealed bromocriptine did not improve nonfluent aphasia. Copyright © 2006 by AAN Enterprises, Inc.